{"pub": "marketwatch", "url": "https://marketwatch.com/articles/canopys-stock-is-down-because-of-an-analysts-dim-view-on-pot-players-51568995784", "downloaded_at": "2019-09-21 14:45:15.620634+00:00", "title": "Canopy\u2019s Stock Is Down Because of an Analyst\u2019s Dim View on Pot Players", "language": "en", "text": "Canopy Growth stock has slid more than 10% over the past two days, despite a buoyant market. One thing weighing on the shares (ticker: CGC) may have been a report by MKM Partners that argues that the Canadian cannabis pioneer overpaid its executives and produced way more weed than it has sold.\n\nThe brokerage firm\u2019s Canopy critique on Thursday was one of several initial reports by analyst Bill Kirk, who also launched coverage of big weed producers Aurora Cannabis (ACB), Tilray (TLRY), Cronos Group (CRON), and Curaleaf Holdings...", "description": "Investors\u2019 expectations for cannabis companies like Canopy, Aurora, Tilray, Cronos and Curaleaf are just too high, says one MKM Partners analyst.", "authors": ["Bill Alpert"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DF619_Canopy_OR_20190920093510.jpg", "published_at": "2019-09-20"}